Australia Grants Stem Cell Line To Disgraced S. Korea Researcher
This article was originally published in PharmAsia News
Executive Summary
South Korea's disgraced stem cell scientist has been granted a patent in Australia for a line of cloned human embryo stem cells for research. Hwang Woo-suk was fired by Seoul National University after it was discovered he falsified parts of his groundbreaking research that gained international attention. He is still on trial in South Korea on charges of fraud and violating bioethics laws. The new stem cell line now protected in Australia is the same NT-1 line he worked on, but which was discovered to have been grown from unfertilized eggs, contrary to his claim to have produced the first cloned embryo. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.